Page last updated: 2024-11-02

pentamidine and Leukemia L 1210

pentamidine has been researched along with Leukemia L 1210 in 2 studies

Pentamidine: Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.
pentamidine : A diether consisting of pentane-1,5-diol in which both hydroxyl hydrogens have been replaced by 4-amidinophenyl groups. A trypanocidal drug that is used for treatment of cutaneous leishmaniasis and Chagas disease.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Libby, PR1
Porter, CW1
Pérez, JM1
Navarro-Ranninger, MC1
Requena, JM1
Jimenéz-Ruiz, A1
Parrondo, E1
Craciunescu, D1
López, MC1
Alonso, C1

Other Studies

2 other studies available for pentamidine and Leukemia L 1210

ArticleYear
Inhibition of enzymes of polyamine back-conversion by pentamidine and berenil.
    Biochemical pharmacology, 1992, Aug-18, Volume: 44, Issue:4

    Topics: Acetyltransferases; Animals; Diminazene; Humans; Kinetics; Leukemia L1210; Melanoma; Mice; Oxidoredu

1992
DNA binding properties and antileukemic (L1210) activity of a Pt-pentamidine complex.
    Chemico-biological interactions, 1991, Volume: 77, Issue:3

    Topics: Animals; Carboplatin; Cisplatin; DNA; Drug Stability; Kinetics; Leukemia L1210; Magnetic Resonance S

1991